Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance

Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance

Item
http://www.wikidata.org/entity/Q34536974
Pharmacologic resistance in colorectal cancer: a reviewThymidine Phosphorylase in Cancer; Enemy or Friend?Interactive cellular proteins related to classical swine fever virus non-structure protein 2 by yeast two-hybrid analysis.CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer.Transcriptome-wide identification and study of cancer-specific splicing events across multiple tumors.The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.Alternative Splicing of Neuronal Differentiation Factor TRF2 Regulated by HNRNPH1/H2Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance.Alternative splicing and cell survival: from tissue homeostasis to disease.Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing.The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains.Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.Drug resistance and new therapies in colorectal cancer
P2860

Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistance

Item
http://www.wikidata.org/entity/Q34536974
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@ast
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@en
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@nl
type
label
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@ast
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@en
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@nl
prefLabel
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@ast
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@en
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Heterogeneous nuclear ribonucl ...... in anticancer drug resistance
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932